Virtu Financial LLC Oric Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	BUY	$8.04 - $16.03 $131,630 - $262,443	16,372 New	16,372 $225,000
Q3 2023 Nov 14, 2023	BUY	$6.05 - $9.28 $46,161 - $70,806	7,630 Added 64.49%	19,461 $118,000
Q2 2023 Jul 27, 2023	SELL	$4.95 - $8.4 $38,575 - $65,461	-7,793 Reduced 39.71%	11,831 $92,000
Q1 2023 May 01, 2023	BUY	$4.26 - $6.75 $83,598 - $132,462	19,624 New	19,624 $112,000
Q2 2022 Aug 09, 2022	SELL	$2.7 - $7.07 $28,479 - $74,574	-10,548 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$4.54 - $16.1 $47,887 - $169,822	10,548 New	10,548 $56,000
Q3 2020 Dec 11, 2020	SELL	$19.5 - $31.26 $120,256 - $192,780	-6,167 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$25.68 - $38.12 $158,368 - $235,086	6,167 New	6,167 $208,000

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.